Trial Profile
Double-blind, single oral dose escalation study investigating the safety, tolerability, and pharmacokinetics of intravenously administered BC 3781 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2010
Price :
$35
*
At a glance
- Drugs Lefamulin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Respiratory tract infections; Skin and soft tissue infections
- Focus Adverse reactions
- 15 Sep 2010 Results were reported at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 15 Sep 2010 New trial record